|
1) |
Martinez AA, Pataki I, EdmundsonG, et al. Phase II prospective study of the use of conformal high-dose rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer a feasibility report. Int J Radiat Oncol Biol Phys. 2001;49:61-9. |
2) |
Martin T, Baltas D, Kurek R, et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol. 2004;180:225-32. |
3) |
Yoshioka Y, Nose T, Yoshida K, et al. High-dose-rate interstitial barchytherapy as a monotherapy for localized prostate cancer:treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys. 2000;48:675-81. |
4) |
Grills IS, Martinez AA, Hollander M, et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol. 2004;171:1098-104. |
5) |
Rodriguez R, et al. High dose rate brachytherapy for prostatic cancer:assessment of current clinical practice and the recommendations of the American brachytherapy society. J Brachytherapy Int. 2001;17:265-82. |
6) |
Kovacs G, Potter R, Loch T, et al. GEC/ESTRO-EAU recommendation on temporary brachytherapy using stepping sources for localized prostate cancer. Radiother Oncol. 2005;74:137-48. |